U.S. PHARMACOPEIA

Search USP29  
Carbenicillin Disodium
Click to View Image
C17H16N2Na2O6S (anhydrous) 422.36

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(carboxyphenylacetyl)amino]-3,3-dimethyl-7-oxo-, disodium salt, [2S-(2,5,6)]-.

N-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo.[3.2.0]- hept-6-yl)- 2-phenylmalonamic acid disodium salt [4800-94-6].
» Carbenicillin Disodium has a potency equivalent to not less than 770 µg of carbenicillin (C17H18N2O6S) per mg, calculated on the anhydrous basis.
Packaging and storage— Preserve in tight containers.
Labeling— Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
Identification— It responds to the tests for Sodium 191.
pH 791: between 6.5 and 8.0, in a solution containing 10 mg of carbenicillin per mL.
Water, Method I 921: not more than 6.0%.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Other requirements— Where the label states that Carbenicillin Disodium is sterile, it meets the requirements for Sterility and Bacterial endotoxins under Carbenicillin for Injection. Where the label states that Carbenicillin Disodium must be subjected to further processing during the preparation of injectable dosage forms, it meets the requirements for Bacterial endotoxins under Carbenicillin for Injection.
Assay—
Assay preparation— Dissolve a suitable quantity of Carbenicillin Disodium, accurately weighed, in Buffer No. 1, and dilute quantitatively with Buffer No. 1 to obtain a solution having a convenient concentration of carbenicillin.
Procedure— Proceed as directed under Antibiotics—Microbial Assays 81, using an accurately measured volume of Assay preparation diluted quantitatively with Buffer No. 1 to yield a Test Dilution having a concentration assumed to be equal to the median dose level of the Standard.
Auxiliary Information— Staff Liaison : Brian D. Gilbert, Ph.D., Scientist
Expert Committee : (MDANT05) Monograph Development-Antibiotics
USP29–NF24 Page 374
Phone Number : 1-301-816-8223